Targeting coagulation activation in severe COVID-19 pneumonia: lessons from bacterial pneumonia and sepsis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting coagulation activation in severe COVID-19 pneumonia: lessons from bacterial pneumonia and sepsis
Authors
Keywords
-
Journal
European Respiratory Review
Volume 29, Issue 157, Pages 200240
Publisher
European Respiratory Society (ERS)
Online
2020-10-01
DOI
10.1183/16000617.0240-2020
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Abnormal Coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
- (2020) Ning Tang et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Targeting potential drivers of COVID-19: Neutrophil extracellular traps
- (2020) Betsy J. Barnes et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Tocilizumab treatment in COVID-19: A single center experience
- (2020) Pan Luo et al. JOURNAL OF MEDICAL VIROLOGY
- Hypercoagulability of COVID‐19 patients in Intensive Care Unit. A Report of Thromboelastography Findings and other Parameters of Hemostasis
- (2020) Mauro Panigada et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
- (2020) Maximilian Ackermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients
- (2020) Jing Liu et al. EBioMedicine
- Bivalirudin for Maintenance Anticoagulation During Venovenous Extracorporeal Membrane Oxygenation for COVID-19
- (2020) Troy G. Seelhammer et al. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA
- The hazard of (sub)therapeutic doses of anticoagulants in non‐critically ill patients with Covid‐19: the Padua province experience
- (2020) Raffaele Pesavento et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Chronic Therapeutic Anticoagulation is Associated with Decreased Thrombotic Complications in SARS‐CoV‐2 Infection
- (2020) Daniel J. Lachant et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy
- (2020) Corrado Lodigiani et al. THROMBOSIS RESEARCH
- Coagulation abnormalities and thrombosis in patients with COVID-19
- (2020) Marcel Levi et al. Lancet Haematology
- Vascular occlusion by neutrophil extracellular traps in COVID-19
- (2020) Moritz Leppkes et al. EBioMedicine
- Streptokinase versus Unfractionated Heparin Nebulization in Patients with Severe Acute Respiratory Distress Syndrome (ARDS): A Randomized Controlled Trial with Observational Controls
- (2019) Ahmed Abdelaal Ahmed Mahmoud et al. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA
- Meta-Analysis of Preclinical Studies of Fibrinolytic Therapy for Acute Lung Injury
- (2018) Cong Liu et al. Frontiers in Immunology
- Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patients
- (2018) Andrea T. Obi et al. Journal of Vascular Surgery-Venous and Lymphatic Disorders
- Nebulized Recombinant Human Tissue Factor Pathway Inhibitor Attenuates Coagulation and Exerts Modest Anti-inflammatory Effects in Rat Models of Lung Injury
- (2017) Florry E. van den Boogaard et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- More than an anticoagulant: Do heparins have direct anti-inflammatory effects?
- (2017) Timothy J. Poterucha et al. THROMBOSIS AND HAEMOSTASIS
- Regulation of Neutrophilic Inflammation by Proteinase-Activated Receptor 1 during Bacterial Pulmonary Infection
- (2015) Ricardo J. José et al. JOURNAL OF IMMUNOLOGY
- Regulation of neutrophilic inflammation in lung injury induced by community-acquired pneumonia
- (2015) Ricardo José et al. LANCET
- Feasibility and Safety of Local Treatment with Recombinant Human Tissue Factor Pathway Inhibitor in a Rat Model of Streptococcus pneumoniae Pneumonia
- (2015) Florry E. van den Boogaard et al. PLoS One
- Recombinant Human Activated Protein C in the Treatment of Acute Respiratory Distress Syndrome: A Randomized Clinical Trial
- (2014) Alexander D. Cornet et al. PLoS One
- PAR-1 contributes to the innate immune response during viral infection
- (2013) Silvio Antoniak et al. JOURNAL OF CLINICAL INVESTIGATION
- Activated protein C attenuates pulmonary coagulopathy in patients with acute respiratory distress syndrome
- (2013) A. D. Cornet et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Nebulized Fibrinolytic Agents Improve Pulmonary Fibrinolysis but Not Inflammation in Rat Models of Direct and Indirect Acute Lung Injury
- (2013) Jorrit J. Hofstra et al. PLoS One
- Proteinase-activated receptors in fibroproliferative lung disease
- (2013) Ricardo J José et al. THORAX
- Plasminogen Controls Inflammation and Pathogenesis of Influenza Virus Infections via Fibrinolysis
- (2013) Fatma Berri et al. PLoS Pathogens
- Microparticles and acute lung injury
- (2012) Mark McVey et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46
- (2012) L. O. Mosnier et al. BLOOD
- PAR1 contributes to influenza A virus pathogenicity in mice
- (2012) Khaled Khoufache et al. JOURNAL OF CLINICAL INVESTIGATION
- Protease-activated receptor-1 cleaved at R46 mediates cytoprotective effects
- (2012) R. A. SCHUEPBACH et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Vorapaxar in the Secondary Prevention of Atherothrombotic Events
- (2012) David A. Morrow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drotrecogin Alfa (Activated) in Adults with Septic Shock
- (2012) V. Marco Ranieri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recombinant Tissue Factor Pathway Inhibitor in Severe Community-acquired Pneumonia
- (2011) Richard G. Wunderink et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The impact of coagulation parameters on the outcomes of patients with severe community-acquired pneumonia requiring intensive care unit admission
- (2011) Jorge I.F. Salluh et al. JOURNAL OF CRITICAL CARE
- Inhibition of SARS Pseudovirus Cell Entry by Lactoferrin Binding to Heparan Sulfate Proteoglycans
- (2011) Jianshe Lang et al. PLoS One
- Bivalirudin versus Unfractionated Heparin for Prevention of Hemofilter Occlusion During Continuous Renal Replacement Therapy
- (2010) Tyree H Kiser et al. PHARMACOTHERAPY
- Procoagulant alveolar microparticles in the lungs of patients with acute respiratory distress syndrome
- (2009) Julie A. Bastarache et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Endogenous EPCR/aPC-PAR1 signaling prevents inflammation-induced vascular leakage and lethality
- (2009) F. Niessen et al. BLOOD
- Antithrombin inhibits bronchoalveolar activation of coagulation and limits lung injury during Streptococcus pneumoniae pneumonia in rats*
- (2009) Goda Choi et al. CRITICAL CARE MEDICINE
- The impact of time on the systemic inflammatory response in pneumococcal pneumonia
- (2009) E. Calbo et al. EUROPEAN RESPIRATORY JOURNAL
- Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study
- (2009) Richard C Becker et al. LANCET
- Protection of vascular barrier integrity by activated protein C in murine models depends on protease-activated receptor-1
- (2009) Reto A. Schuepbach et al. THROMBOSIS AND HAEMOSTASIS
- Lung Inflammation Induced by Lipoteichoic Acid or Lipopolysaccharide in Humans
- (2008) Jacobien J. Hoogerwerf et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Randomized Clinical Trial of Activated Protein C for the Treatment of Acute Lung Injury
- (2008) Kathleen D. Liu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The Haemostatic Role of Tissue Factor Pathway Inhibitor
- (2007) James T.B. Crawley et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started